ED
55
3
SO
62
3
GILD
54
3
VRSK
82
2
WM
82
2
RIG
55
-6
SWK
67
-4
IRM
52
2
AMZN
59
3
ABBV
50
8
AAL
51
-3
LYB
41
-2
CMS
64
4
RSG
76
2
NVDA
54
2
EXPE
93
2
FLR
56
-2
BLK
61
-2
LUV
42
-3
MSI
73
3
ED
55
3
SO
62
3
GILD
54
3
VRSK
82
2
WM
82
2
RIG
55
-6
SWK
67
-4
IRM
52
2
AMZN
59
3
ABBV
50
8
AAL
51
-3
LYB
41
-2
CMS
64
4
RSG
76
2
NVDA
54
2
EXPE
93
2
FLR
56
-2
BLK
61
-2
LUV
42
-3
MSI
73
3
Financhill
Back

ProShares UltraPro Short 20+ Year Trs Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
44

TTT
ProShares UltraPro Short 20+ Year Trs

Last Price:
68.79
Seasonality Move:
-2.65%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
135.34
Seasonality Move:
14.88%
Sell
44
ProShares UltraPro Short 20+ Year Trs (TTT) is a Sell

Is ProShares UltraPro Short 20+ Year Trs a Buy, Sell or Hold?

  • The current ProShares UltraPro Short 20+ Year Trs [TTT] share price is $70.75. The Score for TTT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • TTT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TTT Stock Price Chart

What is ProShares UltraPro Short 20+ Year Trs's stock price today?

  • The ProShares UltraPro Short 20+ Year Trs share price today is $70.75
    The current trend is moderately bearish and TTT is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TTT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.18 Buy
Relative Strength Index (14 RSI): 46.71 Sell
Chaikin Money Flow: -11936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71 - 75.34) Sell
Bollinger Bands (100): (59.62 - 72.32) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

TTT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.26 Sell
20-day SMA: 73.48 Sell
50-day SMA: 68.38 Buy
200-day SMA: 70.5 Buy
8-day EMA: 73.25 Sell
20-day EMA: 72.91 Sell
50-day EMA: 69.92 Buy
200-day EMA: 70.15 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares UltraPro Short 20+ Year Trs Earnings Growth & TTT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares UltraPro Short 20+ Year Trs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):